✦ LIBER ✦

P.01.20 SAFETY OF LONG-TERM INFLIXIMAB AND ADALIMUMAB TREATMENTS IN CROHN'S DISEASE

✍ Scribed by Mazzuoli, S.; Regano, N.; Guglielmi, F.W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P426 Long-term safety of adalimumab in p

✍ Rosh, J.; Ruemmele, F.; Dubinsky, M.; Escher, J.; Kierkus, J.; Hyams, J.; Lazar, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 64 KB

P052 LONG-TERM EFFICACY AND SAFETY OF AD

✍ K. Karmiris; M. Noman; F. Schnitzler; H. Fidder; I.E. Koutroubakis; E.A. Kouroum 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 73 KB

Infliximab in Crohn's disease: early and

✍ A. Armuzzi; B. De Pascalis; P. Fedeli; F. De Vincentis; A. Gasbarrini 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 147 KB

63 P Long term infliximab treatment of a

✍ F. Morace; A. Marone; R. Pumpo; A. Savastano; G. Marone 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

P241 Long-term (5 years) efficacy and sa

✍ R. Ferreiro; E. Fernandez-Salgado; V. Ollero; A. Lorenzo Gonzalez; D. Carpio; A. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

W1221 Long-Term Efficacy and Safety of A

✍ Karmiris, Konstantinos; Noman, Maja; Schnitzler, Fabian; Fidder, Herma; Koutroub 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 82 KB